Xtant Medical Holdings, Inc. (XTNT) News
Follow Xtant Medical Holdings, Inc. (XTNT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Xtant Medical Withdraws 2026 Guidance After $3.6M Q3 Loss
Q3 revenue was $24.3 million, down from $33.3 million a year earlier but up 5% sequentially. Xtant reported a $3.6 million net loss, versus $1.3 million in net income a year earlier, and withdrew its prior 2026 guidance
EQUITY | Nov 16, 2026, 12:09 PM UTC
L
Xtant Medical Holdings price target set at $1 by LUCID Capital Markets
Benzinga reports a ratings action for Xtant Medical Holdings, with a $1.00 per-share price target announced by LUCID Capital Markets.
EQUITY | Sep 02, 2026, 01:22 PM UTC
L
Xtant Medical announces exclusive partnership with BioHorizons
Xtant Medical said it has an exclusive partnership with BioHorizons to expand access to its allogeneic growth factor in the dental market.
EQUITY | Aug 27, 2026, 12:00 PM UTC
L
Xtant Medical Hldgs Lowers FY2026 Sales Guidance from $101.000M-$105.000M to $99.000M-$103.000M vs $102.058M Est
Xtant Medical Hldgs (AMEX: XTNT ) lowers FY2026 sales outlook from $101.000 million-$105.000 million to $99.000 million-$103.000 million vs $102.058 million estimate.
EARNINGS | Aug 11, 2026, 11:01 AM UTC
L
XTNT XTNT XTNT - Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
XTNT XTNT XTNT - Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
EARNINGS | Aug 06, 2026, 12:00 PM UTC